机器人髋关节外骨骼在门诊卒中康复中的安全性与疗效
结果显示步行速度、步行耐力、平衡、功能性步态及每日步数均显著改善,下肢运动诱发电位可检出率增加35%,提示皮质运动兴奋性改变。
要点
- GEMS-H辅助模式训练18次后步行速度提升0.13 m/s,6分钟步行距离增加47 m。
- Berg平衡量表提高2.93分,功能性步态评估提高1.80分,每日步数平均增加1750步。
- 下肢运动诱发电位可检出率增加35%,内侧腓肠肌主动运动阈值显著下降5.7。
核心结论
- GEMS-H髋关节外骨骼辅助步态训练可显著改善慢性卒中患者步行速度、步行耐力与平衡,并增加日常步数。
- 训练后皮质运动兴奋性改变提示该设备可能有助于纠正卒中后大脑半球间失衡。
研究设计与样本
- 前瞻性、单臂、干预性、纵向研究,在COVID-19疫情期间门诊康复环境下完成。
- 在基线、中点(第9次训练后)、后测(第18次训练后)及1个月随访四个时间点评估基于表现与自报的临床结局。
- 使用踝部佩戴的活动记录设备收集研究期间每日步数,并在基线与后测使用经颅磁刺激测量4块双侧下肢肌肉的皮质运动兴奋性。
主要发现
- 主要结局步行速度提升0.13 m/s(p < 0.001)。
- 6分钟步行试验距离增加47 m(p < 0.001),Berg平衡量表提高2.93分(p < 0.001),功能性步态评估提高1.80分(p < 0.001)。
- 每日步数平均增加1750步/天(p < 0.001)。
- 下肢运动诱发电位可检出率增加35%,内侧腓肠肌主动运动阈值显著下降5.7(p < 0.05)。
临床怎么用
- 在门诊康复环境中,可考虑对慢性卒中患者使用GEMS-H髋关节外骨骼辅助模式进行步态训练,以改善步行速度、耐力与平衡。
- 训练过程中可结合每日步数监测评估日常活动变化,并关注皮质运动兴奋性相关指标作为神经生理学反馈。
局限性
- 研究为单臂设计,无对照组的比较,无法排除自然恢复或训练外因素对结局的影响。
- 研究在COVID-19疫情期间进行,对传统门诊临床环境进行了显著修改以遵守机构物理距离政策及CDC指南,可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to analyze the safety and efficacy of using a robotic hip exoskeleton designed by Samsung Electronics Co., Ltd., Korea, called the Gait Enhancing and Motivating System-Hip (GEMS-H), in assistance mode only with the poststroke population in an outpatient-rehabilitation setting. METHODS: Forty-one participants with an average age of 60 and average stroke latency of 6.5 years completed this prospective, single arm, interventional, longitudinal study during the COVID-19 pandemic. Significant modifications to the traditional outpatient clinical environment were made to adhere to organizational physical distancing policies as well as guidelines from the Centers for Disease Control. All participants received gait training with the GEMS-H in assistance mode for 18 training sessions over the course of 6-8 weeks. Performance-based and self-reported clinical outcomes were assessed at four time points: baseline, midpoint (after 9 training sessions), post (after 18 training sessions), and 1-month follow up. Daily step count was also collected throughout the duration of the study using an ankle-worn actigraphy device. Additionally, corticomotor excitability was measured at baseline and post for 4 bilateral lower limb muscles using transcranial magnetic stimulation. RESULTS: By the end of the training program, the primary outcome, walking speed, improved by 0.13 m/s (p < 0.001). Secondary outcomes of walking endurance, balance, and functional gait also improved as measured by the 6-Minute Walk Test (47 m, p < 0.001), Berg Balance Scale (2.93 points, p < 0.001), and Functional Gait Assessment (1.80 points, p < 0.001). Daily step count significantly improved with and average increase of 1,750 steps per day (p < 0.001). There was a 35% increase in detectable lower limb motor evoked potentials and a significant decrease in the active motor threshold in the medial gastrocnemius (-5.7, p < 0.05) after training with the device. CONCLUSIONS: Gait training with the GEMS-H exoskeleton showed significant improvements in walking speed, walking endurance, and balance in persons with chronic stroke. Day-to-day activity also improved as evidenced by increased daily step count. Additionally, corticomotor excitability changes suggest that training with this device may help correct interhemispheric imbalance typically seen after stroke. TRIAL REGISTRATION: This study is registered with ClinicalTrials.gov (NCT04285060).
引用
- Macaluso R, Giffhorn M, Prokup S, et al. Safety & efficacy of a robotic hip exoskeleton on outpatient stroke rehabilitation. J Neuroeng Rehabil. 2024. PMID: 39080666. doi:10.1186/s12984-024-01421-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。